Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis.
Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system.
The epidemiology of multiple sclerosis: insights to a causal cascade.
Influenza vaccination increases anti-JC virus antibody levels during treatment with Natalizumab: Case report.
Neurological deficit following stereotactic radiosurgery for trigeminal neuralgia.
Disability and progression in Afro-descendant patients with multiple sclerosis.
The obesity-related pathology and Th17 cells.
Anti-MAG autoantibodies are increased in Parkinson's disease but not in atypical parkinsonism.
Induction of gut regulatory CD39(+) T cells by teriflunomide protects against EAE.
Improved treatment satisfaction after switching therapy to rituximab in relapsing-remitting MS.
Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis.
Benefit-Risk Analysis for Decision-Making: An Approach.
Serological prevalence of celiac disease in Brazilian population of multiple sclerosis, neuromyelitis optica and myelitis.
Diagnosis of CCSVI in Meniere syndrome.
Effects of high-speed power training on muscle strength and power in patients with multiple sclerosis.
Myelopathy in systemic lupus erythematosus: clinical, laboratory, radiological and progression findings in a cohort of 1,193 patients.
Humoral response against host-mimetic homologous epitopes of Mycobacterium avium subsp. paratuberculosis in Japanese multiple sclerosis patients.
Orthopaedic manifestations and diagnostic clues in children with Guillain-Barré syndrome.
Progressive Multifocal Leukoencephalopathy in a HIV Negative, Immunocompetent Patient.
Corrigendum.
Mexican Biosimilar Filgrastim for Autologous Hematopoietic Stem Cell Mobilization and Transplantation.
An update on the evidence base for peginterferon β1a in the treatment of relapsing-remitting multiple sclerosis.
Refined clinical scoring in comparative EAE studies does not enhance the chance to observe statistically significant differences.
Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers.
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis.

Pages